Tako‐tsubo cardiomyopathy after observing anaphylaxis

C. Jellis,A. Hunter,R. Whitbourn,A. Macisaac
DOI: https://doi.org/10.1111/j.1445-5994.2009.01926.x
2009-09-01
Abstract:1 Ljung T, Karlén P, Schmidt D, Hellström PM, Lapidus A, Janczewska I et al. Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm county. Gut 2004; 53: 849–53. 2 Ostor AJ, Chilvers ER, Somerville MF, Lim AY, Lane SE, Crisp AJ et al. Pulmonary complications of Infliximab therapy in patients with rheumatoid arthritis. J Rheumatol 2006; 33: 622–8. 3 Villeneuve E, St-Pierre A, Haraoui B. Interstitial pneumonitis associated with Infliximab therapy. Rheumatology 2006; 33: 1189–93. 4 Kramer N, Chuzhin Y, Kaufman L, Ritter J, Rosenstein ED. Methotrexate pneumonitis after initiation of Infliximab therapy for rheumatoid arthritis. Arthritis Rheum 2002; 47: 670–1. 5 Courtney PA, Alderdice J, Whitehead EM. Comment on methotrexate pneumonitis after initiation of Infliximab therapy for rheumatoid arthritis. Arthritis Rheum 2003; 49: 617.
What problem does this paper attempt to address?